6533b85cfe1ef96bd12bd628

RESEARCH PRODUCT

Recommendations for enterovirus diagnostics and characterisation within and beyond Europe

Antonio PirallaPhoebe MakielloAudrey MirandSvein Arne NordbøShamez N LadhaniNatasa BergincOrtwin AdamsJean-luc BaillyJoel PaulIsabelle SchuffeneckerSidsel KrokstadKarin Von EijeHayley CassidyMichael J. GriffithsUrsula MorleyAndrew MacadamEeva BrobergMirabelli CarmenXiaohui Chen NielsenPeter HorbyMieke CarlierSeilesh KadambariHeli HarvalaStavros DerdasMaría CabrerizoPetri SusiKathrin KeerenThea Kølsen FischerSusanne Gjeruldsen DudmanBirgit ProchazkaGaia NebbiaMelanie MaierLaura VanoverscheldeKatja C. WolthersJonathan DeanSofie MidgleyJavier MartinTina Vasehus MadsenSimon CottrellKatherina ZakikhanyRandy PoelmanJohan NeytsManasi MajumdarJavier BuesaCatrin E. MoorePeter SimmondsMargarita Pons-salortAndrés AntónF. Xavier López-labradorSabine DiedrichKimberley S. M. BenschopPeter V. CoyleDavid J. AllenGeorgina McallisterHubert G. M. NiestersCristina MargarettoSheila GovindFausto BaldantiCatherine MooreMaryse A. WiewelJan RichterRobert DyrdakClaus ChristiansenCarita Savolainen-kopraJames MckennaLaura Pellegrinelli

subject

0301 basic medicineEuropean levelRECOMBINATIONNeurological infectionReviewMOUTH-DISEASEmedicine.disease_causeEMERGENCEFecesCentral Nervous System Infections[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesMedicineRespiratory Tract InfectionsCLINICAL SPECIMENSDiagnosticsDiagnostic Techniques and ProceduresComputingMilieux_MISCELLANEOUSEnterovirusEnterovirus D Human3. Good healthEuropeDetectionPCRInfectious DiseasesINFECTIONS[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesRNA ViralRNA INTERNAL CONTROLVp1 capsid proteinVirus isolation[SDV.MP.PRO] Life Sciences [q-bio]/Microbiology and Parasitology/Protistology[SDV.MP.PRO]Life Sciences [q-bio]/Microbiology and Parasitology/ProtistologyVirus03 medical and health sciencesVirologySURVEILLANCEEnterovirus InfectionsJournal ArticleRESPIRATORY VIRUSESddc:610TypingDisease burdenbusiness.industryOutbreakAMPLIFICATIONVirology[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/BacteriologyEnterovirus A Human030104 developmental biologyEnterovirusCapsid Proteins[SDV.MP.BAC] Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology610 Medizin und GesundheitEV typingbusinessEuropean non-polio enterovirus network (ENPEN)

description

Enteroviruses (EV) can cause severe neurological and respiratory infections, and occasionally lead to devastating outbreaks as previously demonstrated with EV-A71 and EV-D68 in Europe. However, these infections are still often underdiagnosed and EV typing data is not currently collected at European level. In order to improve EV diagnostics, collate data on severe EV infections and monitor the circulation of EV types, we have established European non-polio enterovirus network (ENPEN). First task of this cross-border network has been to ensure prompt and adequate diagnosis of these infections in Europe, and hence we present recommendations for non-polio EV detection and typing based on the consensus view of this multidisciplinary team including experts from over 20 European countries. We recommend that respiratory and stool samples in addition to cerebrospinal fluid (CSF) and blood samples are submitted for EV testing from patients with suspected neurological infections. This is vital since viruses like EV-D68 are rarely detectable in CSF or stool samples. Furthermore, reverse transcriptase PCR (RT-PCR) targeting the 5'noncoding regions (5'NCR) should be used for diagnosis of EVs due to their sensitivity, specificity and short turnaround time. Sequencing of the VP1 capsid protein gene is recommended for EV typing; EV typing cannot be based on the 5'NCR sequences due to frequent recombination events and should not rely on virus isolation. Effective and standardized laboratory diagnostics and characterisation of circulating virus strains are the first step towards effective and continuous surveillance activities, which in turn will be used to provide better estimation on EV disease burden. ispartof: Journal of Clinical Virology vol:101 pages:11-17 ispartof: location:Netherlands status: published

10.1016/j.jcv.2018.01.008http://ora.ox.ac.uk/objects/uuid: